시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 방사선량 관리 시장 규모, 점유율 및 동향 분석 보고서 : 제품 및 서비스별, 배포 모드별, 최종 사용자별, 양식별, 용도별, 지역별, 전망 및 예측(2023-2030년)
Global Radiation Dose Management Market Size, Share & Trends Analysis Report By Product & Services (Solution, and Services), By Solution Type, By Mode of Deployment, By End-User, By Modality, By Application, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1432742
리서치사 : KBV Research
발행일 : 2024년 02월
페이지 정보 : 영문 432 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,359,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,431,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 9,004,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

방사선량 관리 시장 규모는 2030년까지 8억 5,810만 달러에 달할 것으로 예상되며, 예측 기간 동안 14.6%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

KBV Cardinal Matrix-방사선량 관리 시장 경쟁 분석

KBV Cardinal matrix의 분석에 따르면 Bayer AG는 이 시장의 선구자이며, 2022년 6월 Bayer AG는 의료 영상용 AI 지원 프로그램을 포함한 디지털 용도에 대한 액세스를 제공하는 플랫폼인 Calantic Digital Solutions를 발표하였습니다, Calantic Digital Solutions는 AI를 사용하여 환자 치료 과정의 중요한 단계에서 방사선과 의사와 그 팀을 지원하기 위해 AI를 사용하는 방사선과용 디지털 도구군입니다. GE HealthCare Technologies, Inc., Siemens Healthineers AG, Canon, Inc. 등의 기업들은 이 시장의 주요 혁신가들입니다.

COVID-19의 영향 분석

팬데믹은 영상 진단 패턴의 변화를 가져왔고, 일상적인 의료 영상 진단은 감소하고 코로나19 진단 및 모니터링과 관련된 영상 진단이 증가했습니다. 이러한 영상 진단의 우선순위 변화는 다양한 영상 진단 양식에서 다양한 방사선량 관리 솔루션에 대한 수요에 영향을 미쳤습니다. 많은 의료 시설들은 신기술 도입을 포함하여 긴급하지 않은 프로젝트를 연기하거나 연기해야 했습니다. 이처럼 코로나19 사태는 방사선량 관리 시장에 부정적인 영향을 미쳤습니다.

시장 성장 요인

의료 영상은 진단과 치료 모두에 필수적이며, 엑스레이, 컴퓨터 단층촬영(CT), 자기공명영상(MRI), 핵의학 등 영상기술의 발전으로 응용 범위가 확대되고 영상 검사 빈도가 증가하고 있습니다. 심혈관 질환, 암, 근골격계 질환과 같은 만성 질환의 유병률 증가는 의료 영상에 대한 수요 증가에 기여하고 있습니다. 영상진단은 이러한 질환의 조기 발견, 진단 및 모니터링에 중요한 역할을 합니다. 따라서 의료용 이미징의 사용이 증가하면서 시장 성장을 주도하고 있습니다. 또한, 전리 방사선 노출과 관련된 잠재적 건강 위험에 대한 인식이 높아지면서 환자 안전에 대한 관심이 높아지고 있습니다. 의료 제공업체와 환자 모두 진단의 정확성을 유지하면서 방사선량을 최소화할 필요성에 대해 더 많이 인식하고 있습니다. 따라서 방사선 노출에 대한 우려가 높아지면서 시장 성장을 견인하고 있습니다.

시장 성장 억제요인

방사선량 관리 시스템을 도입하기 위해서는 많은 선행 투자 비용이 소요됩니다. 의료기관은 선량 관리 기능을 통합하기 위해 소프트웨어 라이선스, 하드웨어 인프라, 경우에 따라서는 새로운 장비 및 기존 시스템의 업그레이드에 투자해야 합니다. 방사선량 관리 솔루션을 전자의무기록(EHR), 영상저장통신시스템(PACS) 등 기존 의료 정보 시스템과 통합하는 것은 복잡하고 비용이 많이 듭니다. 따라서 도입 비용이 시장 성장을 저해하는 요인으로 작용하고 있습니다.

시장의 주요 기업들은 시장 경쟁력을 유지하기 위해 다양한 혁신 제품으로 경쟁하고 있습니다. 위 그림은 이 시장에서 주요 기업의 수익 비율을 보여줍니다. 시장의 주요 기업들은 다양한 산업 수요를 충족시키기 위해 다양한 전략을 채택하고 있습니다. 이 시장의 주요 개발 전략은 제품 출시와 제품 확장입니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요약

제3장 시장 개요

제4장 경쟁 분석 - 세계

제5장 세계의 방사선량 관리 시장 : 제품 및 서비스별

제6장 세계의 방사선량 관리 시장 : 전개 모드별

제7장 세계의 방사선량 관리 시장 : 최종사용자별

제8장 세계의 방사선량 관리 시장 : 모달리티별

제9장 세계의 방사선량 관리 시장 : 용도별

제10장 세계의 방사선량 관리 시장 : 지역별

제11장 기업 개요

제12장 방사선량 관리 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Radiation Dose Management Market size is expected to reach $858.1 million by 2030, rising at a market growth of 14.6% CAGR during the forecast period.

Mammography is a crucial tool for breast cancer screening, which is a common practice for early detection and diagnosis. As the importance of regular mammographic screening grows, there is an increased focus on managing radiation doses to ensure that the benefits of screening are maximized while minimizing potential risks. Consequently, the mammography segment would generate approximately 16.38% share of the market by 2030. The demand for effective dose management solutions arises from balancing mammography's diagnostic accuracy with the imperative to keep radiation doses as low as reasonably achievable.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In November 2023, Canon Medical Systems, a subsidiary of Canon, Inc., has broadened its CT portfolio with the launch of two new scanners: the flagship system, Aquilion ONE/INSIGHT Edition, and the high-throughput system, Aquilion Serve SP. The Aquilion ONE system simplifies high-quality scanning, making it more efficient. Meanwhile, the Aquilion Serve SP enhances clinical confidence for all routine examinations, including trauma and cardiac procedures. Additionally, the Aquilion Serve SP features an 80-cm wide-bore gantry with two easy-to-use touch screens and built-in cameras that support automated one-touch patient positioning. In July 2022, Siemens Healthineers AG has launched Mobilett Impact 1, a mobile X-ray system. Mobilett Impact is an X-ray system used for imaging patients at their bedside, enabling imaging workflow to be carried out right where the patient is. Additionally, the mobile system is designed to provide an optimal radiation dose, addressing one of the biggest challenges in healthcare.

KBV Cardinal Matrix - Radiation Dose Management Market Competition Analysis

Based on the Analysis presented in the KBV Cardinal matrix; Bayer AG is the forerunner in the Market. In June, 2022, Bayer AG unveiled Calantic Digital Solutions, a platform delivering access to digital applications, including AI-enabled programs for medical imaging. Calantic Digital Solutions is a set of digital tools for radiology that use AI to help radiologists and their teams at important stages during a patient's treatment process. And Companies such as GE HealthCare Technologies, Inc., Siemens Healthineers AG, and Canon, Inc. are some of the key innovators in Market.

Covid-19 Impact Analysis

The pandemic led to changes in imaging patterns, with decreased routine medical imaging procedures and increased imaging related to COVID-19 diagnosis and monitoring. These shifts in imaging priorities influenced the demand for radiation dose management solutions differently across various imaging modalities. Many healthcare facilities were compelled to delay or postpone non-urgent projects, including implementing new technologies. Thus, the COVID-19 pandemic had a negative impact on the radiation dose management market.

Market Growth Factors

Medical imaging is essential for both diagnostic and therapeutic purposes. Advancements in imaging technologies, such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine, have expanded the range of applications, leading to a higher frequency of imaging studies. The rising prevalence of chronic diseases, such as cardiovascular diseases, cancer, and musculoskeletal disorders, contributes to the increased demand for medical imaging. Diagnostic imaging plays a crucial role in the early detection, diagnosis, and monitoring of these conditions. Hence, the increasing use of medical imaging procedures is driving the growth of the market. Moreover, Heightened awareness of the potential health risks associated with ionizing radiation exposure has increased the focus on patient safety. Healthcare providers and patients alike are more conscious of the need to minimize radiation doses while maintaining diagnostic accuracy. Therefore, the growing concerns about radiation exposure are propelling the growth of the market.

Market Restraining Factors

Implementing radiation dose management systems often involves significant upfront capital expenses. Healthcare facilities must invest in software licenses, hardware infrastructure, and possibly new equipment or upgrades to existing systems to integrate dose management capabilities. Integrating radiation dose management solutions with existing healthcare information systems, such as electronic health records (EHRs) and picture archiving and communication systems (PACS), can be complex and costly. Thus, the cost of implementation is hampering the growth of the market.

The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Product Launches and Product Expansions.

By Product & Services Analysis

Based on products & services, the market is bifurcated into solutions and services. In 2022, the solution segment garnered the highest revenue share in the market. Healthcare providers increasingly recognize the importance of implementing comprehensive dose management solutions to optimize radiation exposure in medical imaging procedures. The growing awareness of potential risks associated with ionizing radiation and stringent regulatory requirements have fueled the need for advanced tools and technologies.

By Solution Analysis

The solution segment is further subdivided into standalone solutions and integrated solutions. In 2022, the standalone solutions segment attained the largest revenue share in the market. Standalone solutions are often modular and scalable, allowing healthcare providers to implement specific components based on their immediate needs. This flexibility is beneficial for facilities that may not be ready to invest in a comprehensive, integrated system but want to address specific challenges related to radiation dose management.

By Mode of Deployment Analysis

By mode of deployment, the market is segmented into on-premises, cloud, and web-based. The cloud segment procured a remarkable revenue share in the market in 2022. Cloud-based solutions are scalable, allowing healthcare providers to adapt their radiation dose management tools based on changing needs. This scalability is particularly important in the dynamic healthcare environment where imaging volumes and data storage requirements vary. Furthermore, cloud-based tools provide healthcare professionals remote access to radiation dose data and management tools. This accessibility is crucial for healthcare providers who need to monitor and manage dose information from different locations or when working remotely.

By End-User Analysis

Based on end-user, the market is categorized into hospitals & healthcare system, ambulatory surgery centers, diagnostic & imaging center, and others. In 2022, the hospitals and healthcare system segment registered the highest revenue share in the market. Hospitals are increasingly prioritizing patient safety and the delivery of high-quality care. Radiation dose management solutions enable healthcare providers to monitor and control radiation exposure during diagnostic and interventional procedures, ensuring patient safety remains paramount. Effective radiation dose management helps healthcare providers mitigate risks associated with excessive radiation exposure, reducing potential liabilities and enhancing overall patient care outcomes.

By Modality Analysis

On the basis of modality, the market is categorized into computed tomography, fluoroscopy & interventional imaging, radiography, mammography, and nuclear medicine. The radiography segment witnessed a considerable revenue share in the market in 2022. Radiography, which includes X-ray imaging, is one of the most commonly used medical imaging modalities. It is employed for various diagnostic purposes, including imaging of bones, joints, chest, and soft tissues. The widespread use of radiography contributes to this segment's growing demand for effective dose management solutions. Radiography, an ionizing radiation modality, requires careful management to ensure that diagnostic benefits are achieved with the lowest possible radiation dose. Dose management solutions play a crucial role in addressing these patient safety concerns.

By Application Analysis

On the basis of application, the market is segmented into oncology, cardiology, dental, orthopaedic application, and others. The oncology segment recorded the largest revenue share in the market in 2022. Advances in radiation therapy, such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy, have made it possible to deliver more precise and targeted doses of radiation to tumors while minimizing damage to surrounding healthy tissue. Furthermore, regulatory requirements and guidelines related to radiation therapy are also driving the demand for RDM solutions in oncology.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated a substantial revenue share in the market. The Asia Pacific region is witnessing significant investments in healthcare infrastructure development. As new healthcare facilities and imaging centers emerge, there is a growing need for radiation dose management solutions to ensure the safe and efficient use of medical imaging technologies. The increasing prevalence of chronic diseases in Asia requires frequent diagnostic imaging procedures. Radiation dose management becomes crucial in managing the cumulative radiation exposure for patients undergoing multiple imaging studies.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Radiation Dose Management Market Report Segmentation

By Product & Services

By Mode of Deployment

By End-User

By Modality

By Application

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global Radiation Dose Management Market by Product & Services

Chapter 6. Global Radiation Dose Management Market by Mode of Deployment

Chapter 7. Global Radiation Dose Management Market by End-User

Chapter 8. Global Radiation Dose Management Market by Modality

Chapter 9. Global Radiation Dose Management Market by Application

Chapter 10. Global Radiation Dose Management Market by Region

Chapter 11. Company Profiles

Chapter 12. Winning Imperatives of Radiation Dose Management Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기